University of Virginia Cancer Center
- World rank, all time
- #26,984 of 42,892
- Rank in ??
- #483 of 1,041
- Research works
- 131 ▲ 235% vs 2013–17
- Citations
- 3.3k 25.5 per fractional work
- Top-10% rate
- 25.8% record average 16.5%
- Open access
- 61% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.
- Immunology and Microbiology 5.5×
- Biochemistry, Genetics and Molecular Biology 5.2×
- Medicine 2.9×
- Economics, Econometrics and Finance 1.6×
- Health Professions 0.8×
- Chemistry 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Psychology 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Neuroscience 0.0×
- Materials Science 0.0×
- Computer Science 0.0×
Which keywords describe research at University of Virginia Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Lymphoma, Cancer, Cancer Immunotherapy, Prognostic Factors, Chemotherapy, Cancer Therapy and Rituximab.
- m6A-seq
- Therapeutic Antibodies
- Fc Receptors
- PD-1 and PD-L1
- Immunity
- Glycosylation
- Genomic Profiling
- Molecular Profiling
- Genetic Pathogenesis
- Breast Cancer
- Biomarkers
- Targeted Therapy
- Epigenetic Regulation
- Chimeric Antigen Receptor
- PET Imaging
- Leukemia
- Rituximab
- Chemotherapy
- Cancer Immunotherapy
- Cancer
- Immunotherapy
- Lymphoma
- Cancer Therapy
- Prognostic Factors
- Tumor Microenvironment
- Clinical Trials
- CAR T Cells
- Tumor Regression
- Gene Expression
- Transcriptional Regulation
- Classification
- Gene Expression Profiling
- Hodgkin's Lymphoma
- Genetic Mutations
- Gene Expression Regulation
- Immune Checkpoint Blockade
- Monoclonal Antibodies
- Cancer Risk
- Radiotherapy
- Cancer Progression
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy8▲ 19×13 topics
- Cancer5▲ 7.0×23 topics
- Lymphoma5▲ 56×3 topics
- Cancer Immunotherapy4▲ 43×3 topics
- Cancer Therapy4▲ 11×8 topics
- Chemotherapy4▲ 9.2×14 topics
- Prognostic Factors4▲ 15×8 topics
- Rituximab3▲ 38×2 topics
- Tumor Microenvironment3▲ 13×5 topics
- Leukemia3▲ 65×2 topics
- Clinical Trials3▲ 7.7×6 topics
- PET Imaging3▲ 30×3 topics
- CAR T Cells3▲ 62×1 topic
- Chimeric Antigen Receptor3▲ 62×1 topic
- Tumor Regression3▲ 42×2 topics
- Epigenetic Regulation2▲ 19×3 topics
- Gene Expression2▲ 7.0×6 topics
- Targeted Therapy2▲ 18×5 topics
- Transcriptional Regulation2▲ 25×6 topics
- Biomarkers2▲ 5.7×4 topics
- Classification2▲ 8.4×2 topics
- Breast Cancer2▲ 16×7 topics
- Gene Expression Profiling2▲ 44×2 topics
- Genetic Pathogenesis2▲ 67×1 topic
- Hodgkin's Lymphoma2▲ 67×1 topic
- Molecular Profiling2▲ 37×2 topics
- Genetic Mutations2▲ 8.1×5 topics
- Genomic Profiling2▲ 30×2 topics
- Gene Expression Regulation2▲ 28×2 topics
- Glycosylation2▲ 27×2 topics
- Immune Checkpoint Blockade2▲ 26×1 topic
- Immunity2▲ 7.3×5 topics
- Monoclonal Antibodies2▲ 33×2 topics
- PD-1 and PD-L12▲ 26×1 topic
- Cancer Risk2▲ 13×5 topics
- Fc Receptors2▲ 51×1 topic
- Radiotherapy2▲ 7.2×7 topics
- Therapeutic Antibodies2▲ 40×1 topic
- Cancer Progression2▲ 14×2 topics
- m6A-seq2▲ 29×1 topic
Which research topics does University of Virginia Cancer Center publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 3 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 5 RNA modifications and cancer Molecular Biology 2 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 7 Cancer-related molecular mechanisms research Cancer Research 1 works
- 8 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 9 Immunotherapy and Immune Responses Immunology 1 works
- 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has University of Virginia Cancer Center's research output changed?
Output in 2018–2022 was 235% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.